News
Bealmear accepted a four-month suspension, but he argues that the substance in question neither contained a banned substance, ...
Me is teetering on the edge of bankruptcy and actively seeking a buyer. That buyer, unless explicitly restricted, could gain ...
Muscat: The Ministry of Health, represented by the Drug Safety Centre, has introduced a comprehensive set of regulations to ...
Rigorous answers about the program’s effects on drug innovation are still a ways off. However, some information about ...
Republican senators John Cornyn and Chuck Grassley and Democratic Sen. Amy Klobuchar are rolling out a bipartisan measure to ...
From the perspective of compliance, voting rights entrustment is obviously superior; from the perspective of concealment and ...
Claude 4’s “whistle-blow” surprise shows why agentic AI risk lives in prompts and tool access, not benchmarks. Learn the 6 ...
The act targets the health insurance middlemen that manage members' prescription drug benefits on behalf of the plans, ...
High inflation has seen a reduction in the real value of wage rates — so while it’s good news the Fair Work Commission ...
Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...
Challenges, Innovations, and Hope for the FutureClinical trials are the foundation of modern medicine, guiding the ...
Joining with Democratic U.S. Sen. Jeanne Shaheen of New Hampshire, Missouri’s senior GOP senator wants to end federal subsidies for drug company advertising.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results